FLUCIL flucloxacillin (as sodium) 125mg/5mL oral solution bottle أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

flucil flucloxacillin (as sodium) 125mg/5ml oral solution bottle

aspen pharmacare australia pty ltd - flucloxacillin sodium monohydrate, quantity: 27.2 mg/ml (equivalent: flucloxacillin, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: ammonium glycyrrhizinate; sodium benzoate; sucrose; saccharin sodium; disodium edetate; sodium citrate; erythrosine; flavour - for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

FLUCIL flucloxacillin (as sodium) 250mg/5mL oral solution bottle أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

flucil flucloxacillin (as sodium) 250mg/5ml oral solution bottle

aspen pharmacare australia pty ltd - flucloxacillin sodium monohydrate, quantity: 54.4 mg/ml (equivalent: flucloxacillin, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: erythrosine; sodium citrate; sodium benzoate; sucrose; ammonium glycyrrhizinate; disodium edetate; saccharin sodium; flavour - for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

VALCYTE valganciclovir (as hydrochloride) 50 mg/mL powder for oral solution bottle أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

valcyte valganciclovir (as hydrochloride) 50 mg/ml powder for oral solution bottle

pharmaco australia ltd - valganciclovir, quantity: 5 g - solution, powder for - excipient ingredients: mannitol; fumaric acid; sodium benzoate; saccharin sodium; povidone; flavour - valcyte is indicated for the treatment of cytomegalovirus (cmv) retinitis in adult patients with acquired immunodeficiency syndrome (aids). valcyte is indicated for the prophylaxis of cmv disease in adult and paediatric solid organ transplantation (sot) patients who are at risk.